Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neal

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 15, 2018
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experienceDarcy A Krueger, Jamie K Capal, Paolo Curatolo, et al.
Military Medicine|December 4, 2014
Incentives to create and sustain healthy behaviors: technology solutions and research needsDeydre S Teyhen, Matt Aldag, Damon Centola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic reviewLina Chen, George Davey Smith, David M Evans, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 23, 2018
Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV)Eila K Watson, Bethany Shinkins, Lauren Matheson, et al.
The Oncologist|May 7, 2016
The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate CancerElena Castro, Christos Mikropoulos, Elizabeth K Bancroft, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
Lancet (London, England)|November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative GroupAndrew J Vickers, Angel M Cronin, Monique J Roobol, et al.
World Journal of Urology|December 29, 2011
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative groupMonique J Roobol, F H Schröder, Jonas Hugosson, et al.
Annals of the Child Neurology Society|December 27, 2024
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy resultsJamie K Capal, David M Ritter, David Neal Franz, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 15, 2018
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experienceDarcy A Krueger, Jamie K Capal, Paolo Curatolo, et al.
Military Medicine|December 4, 2014
Incentives to create and sustain healthy behaviors: technology solutions and research needsDeydre S Teyhen, Matt Aldag, Damon Centola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic reviewLina Chen, George Davey Smith, David M Evans, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|January 23, 2018
Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV)Eila K Watson, Bethany Shinkins, Lauren Matheson, et al.
The Oncologist|May 7, 2016
The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate CancerElena Castro, Christos Mikropoulos, Elizabeth K Bancroft, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
Lancet (London, England)|November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative GroupAndrew J Vickers, Angel M Cronin, Monique J Roobol, et al.
World Journal of Urology|December 29, 2011
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative groupMonique J Roobol, F H Schröder, Jonas Hugosson, et al.
Annals of the Child Neurology Society|December 27, 2024
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy resultsJamie K Capal, David M Ritter, David Neal Franz, et al.
Pageof 13